LDL apheresis in atherosclerotic disease with hyperlipidemia.

Anaphylactoid reactions, LDL apheresis with dextran sulphate, and ACE inhibitors.

ACE inhibitors and LDL-apheresis with dextran sulphate adsorption.

Genetic and biochemical analyses in dyslipidemic patients undergoing LDL apheresis.

Anaphylatoxin generation and distribution during in vitro LDL apheresis.

HELP LDL apheresis reduces plasma pentraxin 3 in familial hypercholesterolemia.

Effective reduction of plasma LDL levels by LDL apheresis in familial defective apolipoprotein B-100.

LDL-apheresis: results of longterm treatment and vascular outcome.

Pathological and angiographic regression of coronary atherosclerosis by LDL-apheresis in a patient with familial hypercholesterolemia.

Impact of selective LDL apheresis on serum chemerin levels in patients with hypercholesterolemia.

LDL apheresis in a woman with severe heterozygous familial hypercholesterolemia. Late, but not too late.

The HELP-LDL-apheresis multicentre study, an angiographically assessed trial on the role of LDL-apheresis in the secondary prevention of coronary heart disease. I. Evaluation of safety and cholesterol-lowering effects during the first 12 months. HELP Study Group.

Time-dependent Changes of Atherosclerotic LDL Complexes after Smoking Cessation.

LDL apheresis in the treatment of familial hypercholesterolemia: experience of Hospital Santo António, Porto.

Rosuvastatin Enhances the Catabolism of LDL apoB-100 in Subjects with Combined Hyperlipidemia in a Dose Dependent Manner.

The Effect of LDL-Apheresis and Rheohaemapheresis Treatment on Vitamin E.

[The extracorporeal elimination of LDL cholesterol by apheresis. The indications and methods].

Application of an automated plasma filtration device and a blood monitoring system for LDL apheresis.

Antiatherosclerotic Potential of Rhizoma Polygonati Polysaccharide in Hyperlipidemia-induced Atherosclerotic Hamsters.

Bedside monitoring of anti-coagulation under LDL apheresis by means of aPTT testing with a coagulation monitor.

LOX-1 in atherosclerotic disease.

Intracranial atherosclerotic disease.

Increased Wnt5a mRNA Expression in Advanced Atherosclerotic Lesions, and Oxidized LDL Treated Human Monocyte-Derived Macrophages.

Atherosclerotic renovascular disease.

Antioxidant effects of statins in patients with atherosclerotic cerebrovascular disease.

Suggest Documents

Anaphylactoid reactions, LDL apheresis with dextran sulphate, and ACE inhibitors.

ACE inhibitors and LDL-apheresis with dextran sulphate adsorption.

Genetic and biochemical analyses in dyslipidemic patients undergoing LDL apheresis.

Anaphylatoxin generation and distribution during in vitro LDL apheresis.

HELP LDL apheresis reduces plasma pentraxin 3 in familial hypercholesterolemia.

Effective reduction of plasma LDL levels by LDL apheresis in familial defective apolipoprotein B-100.

LDL-apheresis: results of longterm treatment and vascular outcome.

Pathological and angiographic regression of coronary atherosclerosis by LDL-apheresis in a patient with familial hypercholesterolemia.

Impact of selective LDL apheresis on serum chemerin levels in patients with hypercholesterolemia.

LDL apheresis in a woman with severe heterozygous familial hypercholesterolemia. Late, but not too late.

The HELP-LDL-apheresis multicentre study, an angiographically assessed trial on the role of LDL-apheresis in the secondary prevention of coronary heart disease. I. Evaluation of safety and cholesterol-lowering effects during the first 12 months. HELP Study Group.

Time-dependent Changes of Atherosclerotic LDL Complexes after Smoking Cessation.

LDL apheresis in the treatment of familial hypercholesterolemia: experience of Hospital Santo António, Porto.

Rosuvastatin Enhances the Catabolism of LDL apoB-100 in Subjects with Combined Hyperlipidemia in a Dose Dependent Manner.

The Effect of LDL-Apheresis and Rheohaemapheresis Treatment on Vitamin E.

[The extracorporeal elimination of LDL cholesterol by apheresis. The indications and methods].

Application of an automated plasma filtration device and a blood monitoring system for LDL apheresis.

Antiatherosclerotic Potential of Rhizoma Polygonati Polysaccharide in Hyperlipidemia-induced Atherosclerotic Hamsters.

Bedside monitoring of anti-coagulation under LDL apheresis by means of aPTT testing with a coagulation monitor.

LOX-1 in atherosclerotic disease.

Intracranial atherosclerotic disease.

Increased Wnt5a mRNA Expression in Advanced Atherosclerotic Lesions, and Oxidized LDL Treated Human Monocyte-Derived Macrophages.

Atherosclerotic renovascular disease.

Antioxidant effects of statins in patients with atherosclerotic cerebrovascular disease.

LDL apheresis in atherosclerotic disease with hyperlipidemia.

Recommend Documents

Follow Us